First-line Penpulimab (an Anti-Pd1 Antibody) and Anlotinib (an Angiogenesis Inhibitor) with Nab-Paclitaxel/gemcitabine (PAAG) in Metastatic Pancreatic Cancer: a Prospective, Multicentre, Biomolecular Exploratory, Phase II Trial
SIGNAL TRANSDUCTION AND TARGETED THERAPY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要